Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04493385 · ClinicalTrials.gov registry record
The Hepatitis C Transplant Collaborative
A clinical trial of Hepatitis C and Transplant; Failure, Heart, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04493385 is a study of Hepatitis C and Transplant; Failure, Heart that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 500 participants, below the 1,885-participant average among 106 other Hepatitis C trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04493385, a study of Hepatitis C and Transplant; Failure, Heart, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Conditions Studied
Study Locations (1)
Texas
- Baylor Scott & White Health Research Institute - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-09-16 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04493385
The ClinicalTrials.gov registry entry for NCT04493385 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,885-participant average among 106 other Hepatitis C trials with a reported enrollment target (73% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT04493385 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04493385 about?
NCT04493385 is a clinical study titled "The Hepatitis C Transplant Collaborative". In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
What is the current status of trial NCT04493385?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2019-09-16. Estimated completion is 2030-12.
What conditions does trial NCT04493385 study?
This clinical trial studies the following conditions: Hepatitis C, Transplant; Failure, Heart.
Who is sponsoring clinical trial NCT04493385?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04493385 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.